Skip to main content
Clinical Trials/NCT00750646
NCT00750646
Unknown
Not Applicable

The Relationship Between Glaucoma Medication Self-Efficacy, Outcome Expectations, Eye Drop Tech., Adherence and IOP.

Robin, Alan L., M.D.1 site in 1 country220 target enrollmentSeptember 2008
ConditionsGlaucoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma
Sponsor
Robin, Alan L., M.D.
Enrollment
220
Locations
1
Primary Endpoint
Medication adherence measured by MEMS caps
Last Updated
17 years ago

Overview

Brief Summary

This study is interested in monitoring how patients take eye drops, both through video-recordings and adherence monitoring, as well as their perceptions about their eye medications; including the dosing schedules, instillation techniques and effect on their disease.

Registry
clinicaltrials.gov
Start Date
September 2008
End Date
August 2009
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Robin, Alan L., M.D.

Eligibility Criteria

Inclusion Criteria

  • \>18 year old
  • currently taking 1 or more hypotensive topical eye drops takes drops in the right eye for more than 6 months expect to continue drop use for the next 3 months
  • subjects instill their own eye drops
  • subject is able to take HVF tests
  • subject will expect to complete the 3 months enrollment period

Exclusion Criteria

  • unable/unwilling to instill own medications
  • eye drops are discontinued
  • unable to take HVF test
  • unable to complete follow-up
  • investigators discontinue subject for safety reasons
  • not using drops in left eye

Outcomes

Primary Outcomes

Medication adherence measured by MEMS caps

Time Frame: 3 months

Eye drop technique measured by video evaluation

Time Frame: 1 time observation

Secondary Outcomes

  • Intraocular pressure readings(3 months)
  • Medication adherence measured by self-report(3 months)
  • Severity of VF damage(1 test date)

Study Sites (1)

Loading locations...

Similar Trials